GAMMA Investing »

Diamedica Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-09-30 $700 102 6.87

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Ishares Tr Shrt Nat Mun Etf Etf (SUB)
Visa Inc Com Cl A Common Stock (V)
Ishares Tr National Mun Etf Etf (MUB)

View all positions for GAMMA Investing

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
Morgan Stanley
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA

View all funds holding Diamedica Therapeutics